TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
AUM:
₹ 1,295.83 Cr
Expense Ratio
2.11%
Benchmark
NIFTY Pharma TRI
ISIN
INF277K018A5
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Meeta Shetty, Rajat Srivastava
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | 1.94 | 22.69 | 18.06 |
| Nifty Pharma TRI | 0.76 | 20.93 | 15.19 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
30.9565
Last change
-0.15 (-0.4917%)
Fund Size (AUM)
₹ 1,295.83 Cr
Performance
12.15% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund Manager
Meeta Shetty, Rajat Srivastava
Riskometer
HIGH
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.03 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.06 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.88 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.86 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.68 |
| HEALTHCARE GLOBAL ENTERPRISES LTD EQ | 4.68 |
| ASTER DM HEALTHCARE LIMITED EQ | 4.63 |
| ALKEM LABORATORIES LIMITED EQ | 4.46 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 3.95 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 3.86 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 93.37 |
| Chemicals | 2.64 |
| Financial Services | 1.58 |
| Consumer Services | 0.69 |